Purchases and Sales Made in Q1 2023 in Akari Therapeutics PLC (AKTX)
This table provides information about the institutional ownership of Akari Therapeutics PLC (AKTX) during Q1 2023. The information is specifically focused on institutions that hold shares of Akari Therapeutics Plc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Sabby Management, LLC
Upper Saddle River, NJ |
BUY
|
- |
4.27M+ 116.5% |
$641K - $2.31M
|
7.94M
$7.94M
|
|
|
May 12, 2023
Q1 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
228K+ 411.36% |
$34.2K - $123K
|
284K
$284K
|
|
|
May 15, 2023
Q1 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
206K+ 374.2% |
$30.9K - $111K
|
261K
$261K
|
|
|
May 11, 2023
Q1 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
237New |
$35.6 - $128
|
237
$237
|
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|